SOPHiA GENETICS SA
SOPH
$0.07
Change (1 day)
$7.37
Year High
$2.70
Year Low
Categories
SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.
SOPHiA GENETICS SA (SOPH) - Company Outlook
Company Outlook
| Year | Receivables | Debt | Liabilities | Assets | Current Assets |
|---|---|---|---|---|---|
| 2023 | 15.21 M | -104,650,000 | 54.71 M | 206.16 M | 148.05 M |
| 2022 | 6.65 M | -144,562,000 | 43.71 M | 243.84 M | 196.26 M |
| 2021 | 7.09 M | -179,903,000 | 44.77 M | 320.17 M | 282.86 M |
| 2020 | 7.85 M | -67,376,000 | 31.61 M | 132.12 M | 109.69 M |
| 2019 | 9.71 M | -9,605,000 | 29.4 M | 51.66 M | 33.76 M |